Onos Health has raised $17 million in Series A funding to expand its AI-powered clinical intelligence platform for behavioural-health insurers, with Costanoa Ventures leading the round and Flare Capital Partners and CVS Health Ventures participating. The company says Aetna is already among the health plans deploying its software.
Behavioural health, but as a data problem
Behavioural-health spending has ballooned across US insurers as demand for mental-health and substance-use services outstrips capacity, but the market is notoriously hard to manage: care decisions depend on clinical context that generic claims-automation tools cannot see. Onos Health is trying to close that gap with a system that combines clinical rules with machine-learning models to review care patterns, flag inappropriate utilisation and support treatment and spending decisions across an insurer's book of business.
The wedge is utilisation review
Utilisation management sits at the intersection of clinical judgement and financial control, which is exactly where Onos wants to play. Insurers have strong incentives to identify unnecessary or ineffective spending, but they also face regulatory and reputational risk if they deny care too aggressively. Onos is pitching its software as a way to raise the quality of that trade-off rather than automate it away — a positioning that matches a broader shift in healthcare AI from administrative copilots toward tools that influence how care resources are allocated.
Strategic backers
Costanoa Ventures has built a portfolio of applied-AI healthcare companies over the last two years, and Flare Capital is a specialist healthtech investor. But it is CVS Health Ventures' participation that reads as the strongest signal: a strategic backer that operates one of the largest US health-insurance and pharmacy platforms is buying into a company that helps insurers manage behavioural-health economics. Similar strategic-plus-financial patterns appeared in this week's Hike Medical $22.5M raise for orthotics automation.
The wider AI health capital picture
Onos's round is part of a widening pattern in which venture capital is backing narrow, workflow-owning AI companies rather than general-purpose models. Other recent examples include Agentrys's $24.5M for semiconductor-engineering AI agents and Instinct's $250M Series B for consumer AI agents.
Reporting based on coverage from Tech Startups.